Weight-based heparin dosing is more effective in the treatment of postoperative deep vein thrombosis

Archives of Orthopaedic and Trauma Surgery

Volumn 119, Issue 3-4, 1999, Pages 208-211

  Linke, L C ^a   Katthagen, B D ^a  

^a KLINIKUM DORTMUND   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; MONOEMBOLEX;

ANTICOAGULANT THERAPY; ARTICLE; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NOMOGRAM; ORTHOPEDIC SURGERY; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL;

AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BIOMETRY; BODY WEIGHT; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; OSTEOTOMY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS;

EID: 0033002293     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004020050392     Document Type: Article

References (21)

1. Hull RD, Raskob GE (1986) Prophylaxis of venous thromboembolic disease following hip and knee surgery. J Bone Joint Surg [Am] 68: 146-150
2. Lotke PA, Ecker ML, Alavi A, Berkowitz H (1984) Indications for the treatment of deep venous thrombosis following total knee replacement. J Bone Joint Surg [Am] 66:202-208
3. Stulberg BN, Insall JN, Williams GW, Ghelman B (1984) Deep-vein thrombosis following total knee replacement: an analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg [Am] 66: 194-201
4. Barritt DW, Jordon PM (1960) Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1: 1309-1312
5. Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR, Geerts WH (1986) Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med 315:1109-1114
6. Theroux P, Ouimet H, McCans J, Latour JG, Joly P, Levy G (1988) Aspirin, heparin, or both to treat acute unstable angina? N Engl J Med 319:1105-1111
7. Fennerty AG, Thomas P, Backhouse G, Bentley P, Campbell IA, Routledge PA (1985) Audit of control of heparin treatment. BMJ 290:27-28
8. Wheeler AP, Jaquiss RD, Newman JH (1988) Physician practices in the treatment of pulmonary embolism and deep venous thrombosis. Arch Intern Med 148:1321-1325
9. Hull RD, Raskob GE, Rosenbloom D, Lemaire J, Pineo GF, Baylis B (1992) Optimal therapeutic level of heparin therapy in patients with venous thromboembolism. Arch Intern Med 152: 1589-1595
10. Cruickshank MK, Levine MN, Hirsh J, Roberts R, Siguenza M (1991) A standard heparin nomogram for the management of heparin therapy. Arch Intern Med 151:333-337
11. Raschke R.A., Reilly B.M., Guidry J.R., Pharm D., Fontana J.R., Srinivas S (1993) The weight-based heparin dosing nomogram compared with a "standard care" nomogram. Ann Intern Med 119:874-881
12. Hyers TM, Hull RD, Weg JG (1989) Antithrombotic therapy for venous thromboembolic disease. Chest 95:37-51
13. Rosenberg RD (1987) The heparin-antithrombin system: a natural anticoagulant mechanism. In: Colman RW, Hirsh J, Marder VJ (eds) Hemostasis and thrombosis: basic principles and clinical practice, 2nd ed. JB Lippincott, Philadelphia, pp 1373-1392
14. Nordenman B, Bjork I (1978) Binding of low affinity and high affinity heparin to antithrombin: ultraviolet difference spectroscopy and circular dichroism studies. Biochemistry 17:3339-3344
15. Villanueva GB, Danishefsky I (1977) Evidence for a heparin-induced conformational change on antithrombin III. Biochem Biophys Res Commun 74:803-809
16. Niewenhuis H, Albada J, Banga J, Sixma J (1991) Identification of risk factors for bleeding during treatment of acute venous thromboembolism with heparin or low molecular weight heparin. Blood 78:2337-2343
17. Duroux P (1991) A randomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemost 65:251-256
18. Simmoneau G, Charbonnier B, Decousus H (1993) Subcutaneous fixed dose of enoxaparin versus intravenous adjusted dose of unfractionated heparin in the treatment of deep venous thrombosis. Arch Intern Med 153:1541-1546
19. Prandoni P, Lensing AWA, Buller HR, Carta M, Cogo A, Vigo M, Casara D, Ruol A, Cate JW ten (1992) Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 339: 441-445
20. Albada J, Nieuwenhuis HK, Sixma JJ (1989) Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Circulation 80:935-940
21. Lensing AWA, Prins MH, Davidson BL, Hirsh J (1995) Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 155:601-607